CardioCell
Signal active
Organization
Contact Information
Overview
Founded in San Diego, Calif., in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell has an exclusive worldwide license from its parent company, Stemedica, for exploration of therapeutic indications in the cardiovascular field, which includes such indications as acute myocardial Infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD).
About
Industries
Biotechnology, Health Care, Clinical Trials
Founded
2013
Employees
1-10
Headquarters locations
San Diego, California, United States, North America
Social
Profile Resume
CardioCell headquartered in United States, North America, operates in the Biotechnology, Health Care, Clinical Trials sector. With a team of 1-10 employees, CardioCell is actively contributing to advancements in Biotechnology. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
0
Investors
0
Lead Investors
0
Total Funding Amount
$0
Details
0
CardioCell has raised a total of $0 in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
There is no investor info for this profile.
Recent Activity